IL-15, Body Compositition and Insulin Sensivity in Aging

IL-15、身体成分和衰老过程中的胰岛素敏感性

• 批准号: 7365086
• 负责人: LEBRIS S QUINN
• 金额: $ 21.36万
• 依托单位: SEATTLE INST FOR BIOMEDICAL/CLINICAL RES
• 依托单位国家: 美国
• 财政年份: 2006
• 资助国家: 美国
• 起止时间: 2006-03-15 至 2010-12-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7365086
• 关键词: Adipocytes; Adipose tissue; Adult; Affect; Age; Age-Months; Aging; Aging-Related Process; Area; Basic Science; Blood Glucose; Body Composition; Cardiovascular Diseases; Clinical; Condition; Data; Deposition; Development; Diagnostic; Diet; Exhibits; Fasting; Fat-Restricted Diet; Fatty acid glycerol esters; Female; Hormonal; Hormones; Human; Incidence; Inflammation; Insulin; Insulin Resistance; Interleukin-15; Interleukin-2; Interleukin-6; Laboratories; Laboratory mice; Lead; Leptin; Maintenance; Measures; Messenger RNA; Metabolic; Molecular; Monitor; Motor Activity; Mus; Muscle; Non-Insulin-Dependent Diabetes Mellitus; Obesity; Predisposition; Prevention; Production; Protein Overexpression; Rate; Research; Research Personnel; Rodent; Serum; Serum Markers; Signal Pathway; Site; Skeletal Muscle; Skeletal system; Testing; Tissues; Transgenic Mice; Transgenic Organisms; Week; Weight; Work; adiponectin; age related; aged; cohort; cytokine; feeding; food consumption; frailty; improved; insulin secretion; insulin sensitivity; interleukin-15 receptor; mRNA Expression; male; normal aging; oxidation; programs; promoter; protein expression; sarcopenia; wasting; Adipocytes; Adipose tissue; Adult; Affect; Age; Age-Months; Aging; Aging-Related Process; Area; Basic Science; Blood Glucose; Body Composition; Cardiovascular Diseases; Clinical; Condition; Data; Deposition; Development; Diagnostic; Diet; Exhibits; Fasting; Fat-Restricted Diet; Fatty acid glycerol esters; Female; Hormonal; Hormones; Human; Incidence; Inflammation; Insulin; Insulin Resistance; Interleukin-15; Interleukin-2; Interleukin-6; Laboratories; Laboratory mice; Lead; Leptin; Maintenance; Measures; Messenger RNA; Metabolic; Molecular; Monitor; Motor Activity; Mus; Muscle; Non-Insulin-Dependent Diabetes Mellitus; Obesity; Predisposition; Prevention; Production; Protein Overexpression; Rate; Research; Research Personnel; Rodent; Serum; Serum Markers; Signal Pathway; Site; Skeletal Muscle; Skeletal system; Testing; Tissues; Transgenic Mice; Transgenic Organisms; Week; Weight; Work; adiponectin; age related; aged; cohort; cytokine; feeding; food consumption; frailty; improved; insulin secretion; insulin sensitivity; interleukin-15 receptor; mRNA Expression; male; normal aging; oxidation; programs; promoter; protein expression; sarcopenia; wasting

PROJECT SUMMARY: Normal aging in humans and rodents is characterized by reductions-in skeletal muscle mass (termed sarcopenia), as well as by increases in white adipose tissue mass, resulting in an increased fat:lean body composition ratio. Consequences of these changes are age-related increases in the incidence of obesity, cardiovascular disease, insulin resistance, type-2 diabetes, and physical frailty. Recent progress in understanding the hormonal control of body composition has been made through identification of factors produced by adipose tissue which regulate other tissues, including muscle. A reciprocal signaling pathway, in which factors secreted by muscle affect adipose tissue, has not been demonstrated. Interleukin- 15 (IL-15) is an anabolic cytokine whose major site of expression is skeletal muscle. Data from my laboratory indicate IL-15inhibits muscle wasting, reduces adipose tissue mass, and stimulates secretion of the insulin- sensitizing hormone adiponectin. The proposed study will test the hypothesis that age-related declines in IL- 15 secretion by muscle occur, and that maintenance of IL-15 secretion by muscle tissue will inhibit age- associated changes in fat:lean body composition and susceptibility to insulin resistance. The proposed study will utilize two kinds of transgenic mice in which IL-15is overexpressed from a muscle-specific promoter, as well as normally aging mice. The specific aims of the project are to: 1. Characterize changes in muscle IL-15 mRNA and protein expression/secretion, serumIL-15 concentrations, and IL-15receptor mRNA expression in muscle and adipose tissue, during the aging process in normal laboratory mice. 2. Determine if muscle-specific overexpression and/or oversecretion of IL-15in mice inhibit age- associated changes in white adipose tissue and skeletal muscle mass. 3. Determine if muscle-specific overexpression and/or oversecretion of IL-15 in mice inhibit development of obesity and/or insulin resistance in adult and aged mice exposed to a high-fat/high calorie diet. 4. Determine if adult and aged mice which overexpress and/or oversecrete IL-15display difference in food consumption, locomotor activity, metabolic rate, or metabolic substrate utilization. RELEVANCE: This project comprises basic science studies to determine if declines in the IL-15 signaling pathway contribute to the loss of skeletal muscle and increases in fatlean body composition during normal aging. This research may lead to development of improved diagnostic, prevention, or treatment strategies for the common age-associated clinical conditions of frailty, sarcopenia, obesity, insulin resistance, and type-2 diabetes.

项目摘要：人类和啮齿动物的正常衰老的特征是减少骨骼 肌肉质量（称为肌肉减少症），以及白色脂肪组织质量的增加，导致 脂肪增加：瘦体组成比。这些变化的后果是与年龄相关的增加 肥胖，心血管疾病，胰岛素抵抗，2型糖尿病和身体虚弱的发生率。最近的 了解人体组成的荷尔蒙控制的进展是通过识别而做出的 由脂肪组织产生的因素，这些因素调节包括肌肉在内的其他组织。相互信号传导 尚未证明途径，其中肌肉分泌的因素会影响脂肪组织。白痴 15（IL-15）是一种合成代谢细胞因子，其主要表达部位是骨骼肌。我实验室的数据 表明IL-15抑制肌肉浪费，减少脂肪组织质量，并刺激胰岛素的分泌 敏化激素脂联素。拟议的研究将检验以下假设：IL-与年龄相关的下降 15肌肉分泌发生，肌肉组织对IL-15分泌的维持将抑制年龄 脂肪的相关变化：瘦体组成和胰岛素抵抗的易感性。拟议的研究 将利用两种转基因小鼠，其中IL-15IS从肌肉特异性启动子中过表达，作为 以及通常老化的小鼠。该项目的具体目的是： 1。表征肌肉IL-15 mRNA和蛋白质表达/分泌的变化，血清15 衰老期间，肌肉和脂肪组织中的浓度和IL-15受体mRNA表达 正常实验室小鼠的过程。 2。确定IL-15in小鼠的肌肉特异性过表达和/或分泌是否抑制年龄 白色脂肪组织和骨骼肌质量的相关变化。 3。确定小鼠IL-15的肌肉特异性过表达和/或分泌是否抑制 暴露于高脂/高的成年和老年小鼠中肥胖和/或胰岛素抵抗的发展 卡路里饮食。 4。确定成年小鼠是否过表达和/或过度分泌IL-15DISPLAY的差异 食物消耗，运动活性，代谢率或代谢底物利用率。 相关性：该项目包括基础科学研究，以确定IL-15信号传导中是否有所下降 途径有助于骨骼肌的丧失和正常情况下的脂肪体体成分增加 老化。这项研究可能会导致改进的诊断，预防或治疗策略的发展 脆弱，肌肉减少症，肥胖，胰岛素抵抗和类型2的常见年龄相关临床状况 糖尿病。